{"entity":{"id":"nct00186628","kind":"trial","name":"Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD","aka":[],"tldr":"A phase 2 trial of Rituximab, Filgrastim and Granisetron in Leukaemia and Mantle cell lymphoma, run by Stanford University, completed.","summary":"Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD is a phase 2 interventional study registered as NCT00186628 by Stanford University, with 36 participants recorded, started 2005-06 and reaching its primary completion in 2010-11. Interventions recorded: Total lymphoid irradiation, Rituximab, Anti-thymoglobulin, rabbit (ATG, rabbit ATG), Cyclosporine, Mycophenylate mofetil, Filgrastim, Granisetron, Solumedrol, Acetaminophen, Diphenhydramine, Hydrocortisone. Conditions recorded: Leukemia, Mast-Cell, Mantle-cell Lymphoma.\n\nLinked to the drug Granisetron because the registry names it among its interventions and Leukaemia and Mantle cell lymphoma among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT00186628","url":"https://clinicaltrials.gov/study/NCT00186628"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["leukaemia","mantle-cell-lymphoma"],"sections":[],"technologies":[],"targets":[],"drugs":["rituximab","filgrastim","granisetron"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT00186628","phase":"2","setting":"An Open-label, Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of Chronic Graft Versus Host Disease After TLI/ARG Nonmyeloablative Allogeneic Stem Cell Transplantation","sponsor":"Stanford University","enrolled":36,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct00186628/","neighbours":{"cancer":[{"id":"leukaemia","kind":"cancer","name":"Leukaemia (all types)","route":"/cancers/leukaemia/"},{"id":"mantle-cell-lymphoma","kind":"cancer","name":"Mantle cell lymphoma","route":"/cancers/mantle-cell-lymphoma/"}],"drug":[{"id":"filgrastim","kind":"drug","name":"Filgrastim (G-CSF)","route":"/drugs/filgrastim/"},{"id":"granisetron","kind":"drug","name":"Granisetron","route":"/drugs/granisetron/"},{"id":"rituximab","kind":"drug","name":"Rituximab","route":"/drugs/rituximab/"}]}}